Teva CEO steps down, replacement found
When 2022 comes to an end, so too will Kåre Shultz’s time as chief executive officer of Teva, a press release announces.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
EU Commission accuses Teva of breaking antitrust laws
For subscribers
Teva presents positive migraine drug results
For subscribers